Analgesics in Norway delivers a steady performance in 2026, achieving a value of NOK1,222 million and a 3% increase over the previous year, outperforming several Western European peers that faced sharper post-pandemic corrections. This resilience is underpinned by enduring drivers, notably an ageing population, high levels of physical activity, and a consumer base that favours stability over novelty, resulting in sustained demand above pre-2020 levels. The environment remains attractive for established players and is reinforced by entrenched brand loyalty, limited product innovation, and strong trust in professional guidance from pharmacies. With purchasing habits anchored in routine and price transparency now a decisive factor, future growth will depend on optimising channel strategies, enhancing digital engagement, and maintaining advisory services, as incremental gains in e-commerce do not disrupt the strength of established pharmacy and grocery channels.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Norway with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Norway, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Norway report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Norway?
- Which are the leading brands in Analgesics in Norway?
- How are products distributed in Analgesics in Norway?
- How has the regulatory and operating environment for Analgesics changed in Norway?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Stable brand loyalty and ageing population anchors analgesics resilience
Systemic analgesics retains lead as brand loyalty sustains steady demand
Sykepleien’s coverage prompts schools to address adolescent Paracet use
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Pharmacy chains to expand online presence as shoppers compare prices
Systemic analgesics to retain lead as topical solutions accelerate
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Karo Pharma leverages brand trust to sustain dominance
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Grocery stores and pharmacies shape pain relief shopping habits
Online pharmacy platforms attract price-sensitive painkiller buyers
Chart 1 Retail Channels 2021-2026
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!